Hikal Limited (BSE: 524735 | NSE: HIKAL) has signed a multi-year contract with a leading Europe-based global agrochemical company for the development and manufacture of a specialised agrochemical product for international markets. The agreement has been signed through Hikal’s Crop Protection division and marks an important step in expanding the company’s contract development and manufacturing (CDMO) business.
Under the agreement, Hikal will undertake commercial manufacturing and supply of the specialised product to markets worldwide. The contract follows nearly three years of joint work involving process development, technical evaluation and scale-up activities. Hikal successfully completed the development and scale-up programme, demonstrating its ability to meet the customer’s technical and manufacturing requirements.
Commercial supplies are expected to begin towards the end of FY 2026–27. Production volumes are likely to increase gradually as the required regulatory approvals are obtained across different international markets. The agreement strengthens Hikal’s position as a manufacturing partner for global agrochemical companies. It also adds another specialised product to its Crop Protection portfolio and creates an opportunity for long-term business with an established international customer.
Commenting on the development, Sameer Hiremath, Chairman and Managing Director, Hikal Limited, said, “This contract marks an important milestone for our Crop Protection business, converting nearly three years of collaborative development and scale-up into a long-term commercial partnership. It demonstrates Hikal’s ability to combine deep technical expertise with reliable manufacturing capabilities to take complex products from development to commercial supply. We are well positioned to support the planned launch and progressive expansion of supplies across global markets.”
Hikal works with international companies across pharmaceuticals, crop protection, animal health and specialty chemicals. Its services cover research and development, process chemistry, product development, scale-up and commercial manufacturing. The company focuses on supporting customers throughout the product development and manufacturing cycle.
Established in 1988, Hikal manufactures and supplies active ingredients, intermediates and biocides to the global life sciences industry. Its manufacturing facilities are located at Taloja and Mahad in Maharashtra, Panoli in Gujarat and Jigani in Bengaluru. The company also operates a research and technology centre in Pune.
Hikal’s manufacturing facilities have been inspected and certified by global regulatory authorities. The company has also received Responsible Care certification and an EcoVadis Gold Medal, placing it among the top 5% of companies assessed globally for sustainability performance.
